Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 365, Pages 365ra158-365ra158
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-11-17
DOI
10.1126/scitranslmed.aaf9418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fc-gamma receptors: Attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs
- (2016) Carlos J. Bosques et al. AUTOIMMUNITY REVIEWS
- The platelet Fc receptor, FcγRIIa
- (2015) Jianlin Qiao et al. IMMUNOLOGICAL REVIEWS
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
- (2015) Nathaniel Washburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
- (2015) Daniel M. Czajkowsky et al. Scientific Reports
- Targeting the Fc receptor in autoimmune disease
- (2014) Xinrui Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells
- (2014) N. Rieth et al. IMMUNOLOGY LETTERS
- Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies
- (2014) Caitlin Gillis et al. Frontiers in Immunology
- Impact of Immune Complex Size and Glycosylation on IgG Binding to Human Fc Rs
- (2013) A. Lux et al. JOURNAL OF IMMUNOLOGY
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
- (2012) P. Mark Hogarth et al. NATURE REVIEWS DRUG DISCOVERY
- Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
- (2012) Ajay Jain et al. ARTHRITIS RESEARCH & THERAPY
- Nonclinical Evaluation of GMA161—An Antihuman CD16 (FcγRIII) Monoclonal Antibody for Treatment of Autoimmune Disorders in CD16 Transgenic Mice
- (2011) Meghan M. Flaherty et al. TOXICOLOGICAL SCIENCES
- IgG-complex stimulated platelets: A source of sCD40L and RANTES in initiation of inflammatory cascade
- (2010) Adam J. Antczak et al. CELLULAR IMMUNOLOGY
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
- (2010) Kannan Gunasekaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibitory ITAMs as novel regulators of immunity
- (2009) Ulrich Blank et al. IMMUNOLOGICAL REVIEWS
- Unlabeled uses of intravenous immune globulin
- (2008) H. Leong et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started